Minerva Neurosciences (NERV) Non-Current Deferred Tax Liability (2013 - 2021)

Minerva Neurosciences' Non-Current Deferred Tax Liability history runs 9 years deep, the most recent figure standing at $1.8 million for Q3 2021.

• Quarterly Non-Current Deferred Tax Liability changed 0.0% year-over-year to $1.8 million in Q3 2021, while the trailing twelve-month figure through Sep 2021 was $1.8 million (changed 0.0% YoY) and the FY2020 annual result came in at $1.8 million, changed 0.0% from the prior year.
• Non-Current Deferred Tax Liability was $1.8 million for Q3 2021 at Minerva Neurosciences, roughly flat from $1.8 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $13.4 million in Q1 2017 and bottomed at $1.8 million in Q4 2019.
• A 5-year average of $4.6 million and a median of $4.1 million in 2017 frame the typical range for Non-Current Deferred Tax Liability.
• Peak annual rise in Non-Current Deferred Tax Liability reached 0.0% in 2017, while the deepest fall reached 69.8% in 2017.
• Minerva Neurosciences' Non-Current Deferred Tax Liability stood at $4.1 million in 2017, then changed by 0.0% to $4.1 million in 2018, then plunged by 55.55% to $1.8 million in 2019, then changed by 0.0% to $1.8 million in 2020, then changed by 0.0% to $1.8 million in 2021.
• Business Quant data shows NERV's Non-Current Deferred Tax Liability at $1.8 million in Q3 2021, $1.8 million in Q2 2021, and $1.8 million in Q1 2021.